Home/Filings/4/0001209191-22-028797
4//SEC Filing

Yale Kenneth P. 4

Accession 0001209191-22-028797

CIK 0000811240other

Filed

May 12, 8:00 PM ET

Accepted

May 13, 1:35 PM ET

Size

8.2 KB

Accession

0001209191-22-028797

Insider Transaction Report

Form 4
Period: 2022-05-11
Transactions
  • Award

    Restricted Stock Unit

    2022-05-11+40,92740,927 total
    Common Stock (40,927 underlying)
  • Award

    Restricted Stock

    2022-05-11+3,20044,127 total
    Common Stock (3,200 underlying)
Footnotes (3)
  • [F1]At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent.
  • [F2]The restricted stock unit award fully vests and is immediately exercisable upon the one year anniversary of the date of grant.
  • [F3]The restricted stock unit award fully vests and is immediately exercisable upon the filing with the SEC of the Annual Report on Form 10-K for the year ending December 31, 2023.

Issuer

BIOLASE, INC

CIK 0000811240

Entity typeother

Related Parties

1
  • filerCIK 0001926538

Filing Metadata

Form type
4
Filed
May 12, 8:00 PM ET
Accepted
May 13, 1:35 PM ET
Size
8.2 KB